Biosurgery Market Report 2026

Biosurgery Market Overview

• Biosurgery market size has reached to $16.44 billion in 2025 • Expected to grow to $24.59 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Rising Prevalence Of Chronic Diseases Fuels Biosurgery Market Growth • Market Trend: Health Care at Home India Introduces WOW Nurses Program to Improve Wound Care and Patient Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biosurgery Market?

Biosurgery refers to the practice of using live maggots to remove dead tissue from wounds, reduce the risk of infection, and hasten wound healing. It primarily consists of semi-synthetic, synthetic, or natural materials that aid in the healing of surgical incisions and the restoration of tissue. The main biosurgery products are bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcement. The bone graft substitute refers to natural, synthetic, or composite materials that are used to fill up bone deficiencies and encourage bone repair. Natural or biological products and synthetic products are the major sources included. These are used in several applications such as orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, gynecological surgery, and others, and are used by major end-users, such as hospitals, clinics, and others.

What Is The Biosurgery Market Growth Forecast?

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $24.59 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for advanced wound care solutions, rising focus on post-surgical complication reduction, expansion of outpatient surgical procedures, growing investments in biosurgical product innovation, increasing adoption of biologics-based surgery aids. Major trends in the forecast period include increasing adoption of advanced hemostatic agents, rising demand for synthetic surgical sealants, growing use of bio-based adhesion barriers, expansion of minimally invasive surgical solutions, enhanced focus on faster wound healing outcomes.

Global Biosurgery Market Segmentation

1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants And Adhesives, Adhesion Barriers, Staple Line Reinforcement 2) By Source: Natural Or Biologics Products, Synthetic Products 3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications 4) By End-User: Hospitals, Clinics, Other End-Users Subsegments: 1) By Bone-Graft Substitutes: Synthetic Bone Grafts, Natural Bone Grafts 2) By Soft-Tissue Attachments: Mesh Products, Biological Grafts 3) By Hemostatic Agents: Powdered Agents, Gel-based Agents 4) By Surgical Sealants And Adhesives: Fibrin Sealants, Synthetic Sealants 5) By Adhesion Barriers: Absorbable Barriers, Non-absorbable Barriers 6) By Staple Line Reinforcement: Reinforcement Devices, Surgical Staples

What Is The Driver Of The Biosurgery Market?

The increase in the prevalence of chronic disease is expected to propel the growth of the biosurgery market going forward. Chronic disease refers to health problems that persist for a year or longer and necessitate continuing medical care, restricting everyday activities, or both. The main causes of death and disability in the US are chronic diseases such as diabetes, cancer, and heart disease. Biosurgery is used to eliminate dead tissue, lower the risk of infection, and speed up the healing process for chronic wounds. For instance, in September 2025, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, noncommunicable diseases (NCDs) are responsible for 74% of global deaths. Therefore, the increase in the prevalence of chronic disease is driving the growth of the biosurgery industry.

Key Players In The Global Biosurgery Market

Major companies operating in the biosurgery market are Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smith & Nephew plc, Medtronic plc, Stryker Corp., Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom’Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Genzyme Corporation

Global Biosurgery Market Trends and Insights

Major companies operating in the biosurgery market are leveraging advancements in technology, such as advanced wound care technology, to enhance healing outcomes, reduce infection rates, and improve patient recovery times through innovative products and techniques. Advanced wound care technology encompasses innovative methods and products designed to enhance wound healing, prevent infection, and improve patient outcomes. For instance, in September 2024, Health Care at Home India Pvt Ltd, an India-based company that manufactures medical products, launched WOW (Warriors of Woundcare) Nurses. The WOW Nurses initiative seeks to proactively prevent and treat bedsores, common complications for patients with limited mobility. Bedsores can significantly slow recovery, increase hospital stays, and elevate infection risk.

What Are Latest Mergers And Acquisitions In The Biosurgery Market?

In May 2025, Merit Medical Systems, a U.S.-based medical device company specializing in interventional and surgical products, acquired Biolife Delaware LLC for an undisclosed amount. With this acquisition, Merit aims to expand its biosurgery product portfolio by incorporating Biolife’s hemostatic devices such as StatSeal and WoundSeal, thus enhancing its capabilities in surgical bleeding management. BioLife Delaware is a U.S.-based company that develops and manufactures synthetic hemostatic products used in surgical and emergency settings.

Regional Outlook

North America was the largest region in the biosurgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biosurgery Market?

The biosurgery market consists of revenues earned by entities by providing biosurgery services such as maggot therapy, transplantation, and autologous chondrocyte implantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The biosurgery market also includes sales of absorbable hemostats and surgical sealants which are used in providing biosurgery services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biosurgery Market Report 2026?

The biosurgery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biosurgery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.